Last reviewed · How we verify

NCT06046651

Blood Specimen Collection For Laboratory Assay Research

Recruiting now Last updated 14 November 2024
What this trial tests

trial in General; Metabolic Disorder in 10,000 participants. Currently enrolling.

Timeline
16 August 2023
Primary endpoint
31 July 2033
15 August 2033

Quick facts

Lead sponsorRoman Health Ventures Inc.
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment10,000
Start date16 August 2023
Primary completion31 July 2033
Estimated completion15 August 2033
Sites1 location across United States

Conditions studied

Sponsor

Roman Health Ventures Inc.

Who can join

18 and older, any sex, with General; Metabolic Disorder or Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To collect lab data from capillary and venous blood specimens for use in analytical research studies to support the development and validation of laboratory procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06046651.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing